397 related articles for article (PubMed ID: 19517575)
1. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
Bose SK; Gibson W; Giri S; Nath N; Donald CD
Prostate; 2009 Sep; 69(12):1334-42. PubMed ID: 19517575
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
3. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.
Chan LY; Leung JC; Tang SC; Choy CB; Lai KN
J Am Soc Nephrol; 2005 Aug; 16(8):2306-17. PubMed ID: 15930094
[TBL] [Abstract][Full Text] [Related]
4. Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer.
Kosaka T; Miyajima A; Shirotake S; Kikuchi E; Hasegawa M; Mikami S; Oya M
Prostate; 2010 Feb; 70(2):162-9. PubMed ID: 19760626
[TBL] [Abstract][Full Text] [Related]
5. Meconium increases type 1 angiotensin II receptor expression and alveolar cell death.
Rosenfeld CR; Zagariya AM; Liu XT; Willis BC; Fluharty S; Vidyasagar D
Pediatr Res; 2008 Mar; 63(3):251-6. PubMed ID: 18287962
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of AT1 receptor gene on activation of protein kinase Cbeta/nicotinamide adenine dinucleotide diphosphate oxidase/ERK1/2/c-fos signaling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla.
Chan SH; Wang LL; Tseng HL; Chan JY
J Hypertens; 2007 Sep; 25(9):1845-61. PubMed ID: 17762649
[TBL] [Abstract][Full Text] [Related]
7. Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines.
Chow L; Rezmann L; Imamura K; Wang L; Catt K; Tikellis C; Louis WJ; Frauman AG; Louis SN
Prostate; 2008 May; 68(6):651-60. PubMed ID: 18288685
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta1 mediates apoptotic activity of angiotensin II type I receptor blocker on prostate epithelium in vitro.
Zhao Y; Peng J; Zheng L; Yu W; Jin J
Prostate; 2010 Jun; 70(8):899-905. PubMed ID: 20135646
[TBL] [Abstract][Full Text] [Related]
9. [Novel molecular targeting therapeutics for prostate cancer].
Uemura H; Nakaigawa N; Ishiguro H; Kubota Y
Nihon Rinsho; 2005 Feb; 63(2):339-44. PubMed ID: 15714989
[TBL] [Abstract][Full Text] [Related]
10. Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancer.
Guimond MO; Battista MC; Nikjouitavabi F; Carmel M; Barres V; Doueik AA; Fazli L; Gleave M; Sabbagh R; Gallo-Payet N
Prostate; 2013 Jul; 73(10):1057-68. PubMed ID: 23389987
[TBL] [Abstract][Full Text] [Related]
11. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
Das S; Roth CP; Wasson LM; Vishwanatha JK
Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
Zhou J; Xu X; Liu JJ; Lin YX; Gao GD
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1191-8. PubMed ID: 17880376
[TBL] [Abstract][Full Text] [Related]
13. The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.
Zoubeidi A; Rocha J; Zouanat FZ; Hamel L; Scarlata E; Aprikian AG; Chevalier S
Mol Cancer Res; 2009 Jan; 7(1):142-55. PubMed ID: 19147545
[TBL] [Abstract][Full Text] [Related]
14. IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells.
Pitulis N; Papageorgiou E; Tenta R; Lembessis P; Koutsilieris M
Anticancer Res; 2009 Jun; 29(6):2331-7. PubMed ID: 19528499
[TBL] [Abstract][Full Text] [Related]
15. The developmental expression profile of PAX2 in the murine prostate.
Chen Q; DeGraff DJ; Sikes RA
Prostate; 2010 May; 70(6):654-65. PubMed ID: 20017165
[TBL] [Abstract][Full Text] [Related]
16. Involvement of redox-sensitive extracellular-regulated kinases in angiotensin II-induced interleukin-6 expression in pancreatic acinar cells.
Chan YC; Leung PS
J Pharmacol Exp Ther; 2009 May; 329(2):450-8. PubMed ID: 19211919
[TBL] [Abstract][Full Text] [Related]
17. The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.
Levitt RJ; Zhao Y; Blouin MJ; Pollak M
Cancer Lett; 2007 Oct; 255(2):300-6. PubMed ID: 17602833
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II induces oxidative stress in prostate cancer.
Uemura H; Ishiguro H; Ishiguro Y; Hoshino K; Takahashi S; Kubota Y
Mol Cancer Res; 2008 Feb; 6(2):250-8. PubMed ID: 18314486
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone suppresses DU145 cell proliferation and cell cycle through inhibition of the extracellular signal-regulated kinase 1/2 pathway and cyclin D1 expression.
Gao QZ; Lu JJ; Liu ZD; Zhang H; Wang SM; Xu H
Asian J Androl; 2008 Jul; 10(4):635-41. PubMed ID: 18097517
[TBL] [Abstract][Full Text] [Related]
20. Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion?
Ramalho FS; Alfany-Fernandez I; Casillas-Ramirez A; Massip-Salcedo M; Serafín A; Rimola A; Arroyo V; Rodés J; Roselló-Catafau J; Peralta C
J Pharmacol Exp Ther; 2009 Apr; 329(1):130-40. PubMed ID: 19116369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
